Elevance Health Inc (ELV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
Sales | 45,106,000 | 43,886,000 | 42,577,000 | 42,647,000 | 42,849,000 |
Cost of Goods | 38,042,000 | 35,392,000 | 34,371,000 | 36,171,000 | 35,254,000 |
Gross Profit | 7,064,000 | 8,494,000 | 8,206,000 | 6,476,000 | 7,595,000 |
Operating Expenses | 5,391,000 | 5,228,000 | 5,002,000 | 5,216,000 | 5,682,000 |
Operating Income | 1,673,000 | 3,266,000 | 3,204,000 | 1,260,000 | 1,913,000 |
Interest Expense | 300,000 | 280,000 | 265,000 | 259,000 | 259,000 |
Pre-tax Income | 1,373,000 | 2,986,000 | 2,939,000 | 1,001,000 | 1,654,000 |
Income Tax | 365,000 | 685,000 | 690,000 | 170,000 | 354,000 |
Net Income Continuous | 1,008,000 | 2,301,000 | 2,249,000 | 831,000 | 1,300,000 |
Minority Interests | -8,000 | 1,000 | 3,000 | -25,000 | 11,000 |
Net Income | $1,016,000 | $2,300,000 | $2,246,000 | $856,000 | $1,289,000 |
EPS Basic Total Ops | 4.38 | 9.91 | 9.65 | 3.70 | 5.48 |
EPS Basic Continuous Ops | 4.35 | 9.91 | 9.66 | 3.59 | 5.52 |
EPS Diluted Total Ops | 4.36 | 9.85 | 9.59 | 3.68 | 5.45 |
EPS Diluted Continuous Ops | 4.32 | 9.86 | 9.60 | 3.57 | 5.50 |
EPS Diluted Before Non-Recurring Items | N/A | 10.12 | 10.64 | 5.62 | 8.99 |
EBITDA(a) | $2,002,000 | $3,601,000 | $3,535,000 | $1,684,000 | $2,339,000 |